Where does Icare Finland OY rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Icare Finland OY ranks #29,038 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Icare Finland OY hold?

Icare Finland OY holds 9 US utility patents granted between 2016 and 2025, spanning 4 technology areas.

What is Icare Finland OY's Innovation Score?

Icare Finland OY has an Innovation Score of 41.7 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Icare Finland OY focus on?

Icare Finland OY's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 7 patents, ranking #2,341 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Icare Finland OY's patent grant rate increasing or decreasing?

Icare Finland OY's recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Icare Finland OY's patents?

Icare Finland OY's patents average 11.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Icare Finland OY patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Icare Finland OY

USPTO PatentsView assignee record - 9 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Icare ranks #29,038 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 4 technology areas.

#29,038
of 49,997 US assignees by volume: Top 32%
by Innovation Score (41.7/100): 11.1
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29038 · Foreign Corporation #29,038 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,038/49,997
PHOTO-FINISH Iball Instruments
CPC-NARROW A61B · 4 areas
INNOV-PAR 41.7/100
CLAIMS-PAR 11.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Iball Instruments LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Icare’s 41.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (19%) Velocity 20.0 pts (48%) Breadth 7.1 pts (17%) Claim depth 6.7 pts (16%)

Qualcomm Incorporated · highest

85
Icare Finland OY · this assignee

42
3D Lighting… · lowest

7

What this shows Icare's Innovation Score is 41.7/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Icare?

Each dot is one of Icare’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Icare’s own 11.1 claims/patent is ABOVE the 8.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Icare vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Icare's grants concentrate

Icare Finland OY is a focused PatentsView assignee: 4 CPC subclasses with 77.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2016. By volume, Icare sits between Iball Instruments LLC and ID Pharma Co., Ltd..

Icare's three-year grant acceleration

Icare Finland OY shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Iball Instruments

9
Ibaraki University

9
Ibur

9
ICA Trinova

9
ICG Licensing

9
Icon Bioscience

9
Icos

9
ID Pharma

9
Icare Finland OY ◀

9

What this shows Icare holds 9 patents at rank #29,022, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Icare

By rank, the assignees closest to #29,022 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Icare's primary technology class.

Icare's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Icare Finland OY patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	11.1%
2018	1	11.1%
2023	3	33.3%
2024	2	22.2%
2025partial year	2	22.2%

Which technologies does Icare Finland OY patent most?

A61B - DIAGNOSIS; SURGERY; Identification 7

G02B - Optical Elements, Systems OR Apparatus 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Icare Finland OY's patent record in context - here's where to go next.

Icare Finland OY's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 77.8% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #29,038 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Icare Finland OY against Iball Instruments LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.